Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 2671 AL 2685

Transcranial Sonography Findings in Depression in Association With Psychiatric and Neurologic Diseases: A Review

Krogias C, Walter U.

J Neuroimaging. 2016 May;26(3):257-63. doi: 10.1111/jon.12328. Epub 2016 Jan 19.

Nanoparticle transport across the blood brain barrier

Grabrucker AM, Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G.

Tissue Barriers. 2016 Feb 25;4(1):e1153568. doi: 10.1080/21688370.2016.1153568. eCollection 2016 Jan-Mar.

Novel targets for Huntington's disease: future prospects

Mason SL, Barker RA.

Degener Neurol Neuromuscul Dis. 2016 May 4;6:25-36. doi: 10.2147/DNND.S83808. eCollection 2016.

Molybdenum Metallopharmaceuticals Candidate Compounds - The "Renaissance" of Molybdenum Metallodrugs?

Jurowska A, Jurowski K, Szklarzewicz J, Buszewski B, Kalenik T, Piekoszewski W.

Curr Med Chem. 2016;23(29):3322-3342. doi: 10.2174/0929867323666160504103743.

Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding

Ivanova SA, Loonen AJ.

Parkinsons Dis. 2016;2016:6461907. doi: 10.1155/2016/6461907. Epub 2016 Apr 6.

Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review

Zhao T, Hong Y, Li XJ, Li SH.

Front Mol Neurosci. 2016 Apr 21;9:27. doi: 10.3389/fnmol.2016.00027. eCollection 2016.

Engineered BDNF producing cells as a potential treatment for neurologic disease

Deng P, Anderson JD, Yu AS, Annett G, Fink KD, Nolta JA.

Expert Opin Biol Ther. 2016 Aug;16(8):1025-33. doi: 10.1080/14712598.2016.1183641. Epub 2016 May 21.

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease

López-Sendón Moreno JL, García Caldentey J, Trigo Cubillo P, Ruiz Romero C, García Ribas G, Alonso Arias MA, García de Yébenes MJ, Tolón RM, Galve-Roperh I, Sagredo O, Valdeolivas S, Resel E, Ortega-Gutierrez S, García-Bermejo ML, Fernández Ruiz J, Guzmán M, García de Yébenes Prous J.

J Neurol. 2016 Jul;263(7):1390-400. doi: 10.1007/s00415-016-8145-9. Epub 2016 May 9.

Impaired protein degradation in FTLD and related disorders

Götzl JK, Lang CM, Haass C, Capell A.

Ageing Res Rev. 2016 Dec;32:122-139. doi: 10.1016/j.arr.2016.04.008. Epub 2016 May 7.

Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015)

Zádori D, Veres G, Szalárdy L, Klivényi P, Fülöp F, Toldi J, Vécsei L.

Expert Opin Ther Pat. 2016 Jul;26(7):815-32. doi: 10.1080/13543776.2016.1189531. Epub 2016 Jun 7.

Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function

Kamceva M, Benedict J, Nairn AC, Lombroso PJ.

Neural Plast. 2016;2016:8136925. doi: 10.1155/2016/8136925. Epub 2016 Apr 12.

Neurophysiological Features Of Hemiballism

Tai YC, Yin YWK, Ha AD, Adam R, Mahant N, Sue CM, Fung VSC.

Mov Disord Clin Pract. 2016 May 19;4(1):116-120. doi: 10.1002/mdc3.12356. eCollection 2017 Jan-Feb.

Comparison of mHTT Antibodies in Huntington's Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development

Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP.

PLoS One. 2016 May 19;11(5):e0155834. doi: 10.1371/journal.pone.0155834. eCollection 2016.

CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases

Yang W, Tu Z, Sun Q, Li XJ.

Front Mol Neurosci. 2016 Apr 28;9:30. doi: 10.3389/fnmol.2016.00030. eCollection 2016.

Clonic Perseveration after Acute Ischemic Stroke: An Insight into the Pathophysiological Mechanisms

Pedroso JL, Vale TC, Knobel M, Massaud RM, Knobel E.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):e109-10. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.017. Epub 2016 May 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias